Attached files
file | filename |
---|---|
EX-99.02 - EXHIBIT 99.02 - Shangri-La Tibetan Pharmaceuticals, Inc. | dex9902.htm |
EX-99.01 - EXHIBIT 99.01 - Shangri-La Tibetan Pharmaceuticals, Inc. | dex9901.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 25, 2011
Tibet Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
British Virgin Islands | 001-35038 | Not Applicable | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
Room 1701, 17/F
90 Jaffe Rd.
Wanchai, Hong Kong
(Address of Principal Executive Office) (Zip Code)
(852) 9798 5569
(Registrants telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 8.01 | OTHER EVENTS |
On April 25, 2011, the Registrant issued a press release announcing the release of a white paper on the traditional Tibetan medicine industry in China entitled Traditional Tibetan Medicine: New Markets for Tibets Ancient Therapies. The white paper was prepared by Arthur Goldgaber of SmallcapInsights.com.
ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS. |
(a) | Financial statements of businesses acquired. |
Not Applicable.
(b) | Pro forma financial information. |
Not Applicable.
(c) | Shell company transactions. |
Not Applicable.
(d) | Exhibits. |
99.01 | Press Release of April 25, 2011: Paper Describes Chinas Traditional Tibetan Medicine Market and the Growth Opportunities in Chinas Expanding Healthcare Industry | |
99.02 | White Paper: Traditional Tibetan Medicine: New Markets for Tibets Ancient Therapies |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Tibet Pharmaceuticals, Inc. | ||||||||
Date: April 27, 2011 | By: | /S/ TAYLOR Z. GUO | ||||||
Taylor Z. Guo | ||||||||
Chief Executive Officer |
EXHIBIT INDEX
Number |
Description of Exhibit | |
99.01 | Press Release of April 25, 2011: Paper Describes Chinas Traditional Tibetan Medicine Market and the Growth Opportunities in Chinas Expanding Healthcare Industry | |
99.02 | White Paper: Traditional Tibetan Medicine: New Markets for Tibets Ancient Therapies |